Identification of PANoptosis-based signature for predicting the prognosis and immunotherapy response in AML
Our study established and verified a PANoptosis risk signature to predict the survival and immunological treatment response in AML.
Authors
- Jinwei Cai
- Yanan Yu (ORCID: https://orcid.org/0000-0002-8143-6978)
- Jiaqiu Li
- Lu Zhang (ORCID: https://orcid.org/0000-0002-0446-7885)
- Shouwu Guo
- Jiao Ren
- Guiqing Li (ORCID: https://orcid.org/0009-0007-7554-911X)
- Xiaolin Ma (ORCID: https://orcid.org/0000-0002-9762-1668)
- Jiachun Li (ORCID: https://orcid.org/0009-0005-0848-0680)
- Na Liu (ORCID: https://orcid.org/0000-0003-0949-4046)
Institutions
- Quzhou City People's Hospital (CN)
- Second Hospital of Shandong University (CN)
- Weifang University of Science and Technology (CN)
- Weifang University (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e40267
- Citations
- 5
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 2.27